Assessment of the F9 genotype-specific FIX inhibitor risks and characterisation of 10 novel severe F9 defects in the first molecular series of Argentinian patients with haemophilia B

Thromb Haemost. 2013 Jan;109(1):24-33. doi: 10.1160/TH12-05-0302. Epub 2012 Oct 23.


In haemophilia B (HB) (factor IX [FIX] deficiency), F9 genotype largely determines clinical phenotype. Aimed to characterise Argentinian families with HB, this study presents F9 genotype frequencies and their specific FIX inhibitor risk and 10 novel F9 mutations. Ninety-one DNA samples from HB patients and relatives were subjected to a new scheme: a primary screen for large deletions, a secondary screen for point mutations using conformation sensitive gel electrophoresis, DNA-sequencing and bioinformatic analysis. Our unbiased HB population (N=52) (77% with severe, 11.5% moderate and 11.5% mild HB) showed 32 missense (61.5%), including three novel mutations predicting specific structural/functional defects in silico , seven nonsense (13.5%) (one novel), five large deletions, four splice including three novel mutations affecting predicted splicing scores, three indels (two novel) and one Leiden mutation. Our comprehensive HB population included five patients with long-lasting FIX inhibitors: three nonsense (p.E35* (novel), p.R75*, p.W240*) and two entire- F9 deletions. Another patient with an indel (p.A26Rfs*14) developed transient inhibitors. A case-control analysis, based on our global prevalence of 3.05% for developing inhibitors in HB revealed that missense mutations were associated with a low risk odds ratio (OR) of 0.05 and a prevalence of 0.39%, whereas nonsense and entire- F9 deletions had significantly higher risks (OR 11.0 and 32.7) and prevalence (14.3% and 44.5%, respectively). Our cost-effective practical approach enabled identification of the causative mutation in all 55 Argentine families with HB, analysis of the molecular pathology of novel F9 defects and determination of mutation-associated FIX inhibitor risks.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Argentina / epidemiology
  • Autoantibodies / blood
  • Biomarkers / blood
  • Case-Control Studies
  • Codon, Nonsense
  • Computational Biology
  • DNA Mutational Analysis / methods
  • Factor IX / chemistry
  • Factor IX / genetics*
  • Factor IX / immunology
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease
  • Hemophilia B / blood
  • Hemophilia B / diagnosis
  • Hemophilia B / epidemiology
  • Hemophilia B / genetics*
  • Hemostasis / genetics*
  • Humans
  • INDEL Mutation
  • Male
  • Mutation*
  • Mutation, Missense
  • Odds Ratio
  • Pedigree
  • Phenotype
  • Point Mutation
  • Prevalence
  • Protein Conformation
  • Risk Factors
  • Sequence Deletion
  • Severity of Illness Index
  • Structure-Activity Relationship


  • Autoantibodies
  • Biomarkers
  • Codon, Nonsense
  • Factor IX